Filings & corporate actions
- 27 OctresultsResults · Q2 FY27 · consolidated and standalone-2.2%NSE
- 13 OctshareholdingShareholding · 30 Sept 2026+1.0%NSE
- 17 SeptdividendDividend · ₹2.50 per share · record 17 Sept 2026-0.9%
- 24 JulresultsResults · Q1 FY27 · consolidated and standalone+3.3%NSE
- 16 JulshareholdingShareholding · 30 Jun 2026+1.0%NSE
- 30 AprresultsResults · Q4 FY26 · consolidated and standalone+3.2%NSE
- 16 AprshareholdingShareholding · 31 Mar 2026+2.1%NSE
- 28 JanresultsResults · Q3 FY26 · consolidated and standalone+3.8%NSE
- 19 JanshareholdingShareholding · 31 Dec 2025-1.0%NSE
Reaction to results · all yearsrose on day 0 in 14 of 21 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 27 Oct 2026 | -2.2% | -0.4% | — | 3.7× |
| Q1 FY27 | 24 Jul 2026 | +3.3% | -4.4% | -2.7% | 1.2× |
| Q4 FY26 | 30 Apr 2026 | +3.2% | +8.3% | +17.1% | 1.8× |
| Q3 FY26 | 28 Jan 2026 | +3.8% | +6.8% | +16.3% | 3.6× |
| Q2 FY26 | 17 Oct 2025 | +7.1% | +4.1% | +4.4% | 3.8× |
| Q1 FY26 | 30 Jul 2025 | +8.8% | +6.1% | +15.8% | 7.3× |
| Q4 FY25 | 2 May 2025 | +3.5% | +1.9% | -3.2% | 2.2× |
| Q3 FY25 | 29 Jan 2025 | +4.4% | +16.3% | -1.7% | 3.7× |
| Q2 FY25 | 29 Oct 2024 | +5.4% | +14.5% | +17.7% | 6.6× |
| Q1 FY25 | 13 Aug 2024 | -3.8% | +2.8% | +13.6% | 3.0× |
| Q4 FY24 | 12 May 2024 | +2.0% | +3.1% | +2.0% | 3.9× |
| Q3 FY24 | 13 Feb 2024 | +4.8% | +4.9% | +2.1% | 1.5× |
| Q2 FY24 | 9 Nov 2023 | -2.9% | -1.5% | -2.2% | 1.9× |
| Q1 FY24 | 11 Aug 2023 | +4.4% | +5.8% | +2.1% | 2.8× |
| Q4 FY23 | 14 May 2023 | +7.2% | +11.4% | +20.6% | 10.5× |
| Q3 FY23 | 4 Feb 2023 | +2.5% | +4.1% | +8.4% | 2.3× |
| Q2 FY23 | 5 Nov 2022 | -2.2% | -9.4% | -1.3% | 2.0× |
| Q1 FY23 | 10 Aug 2022 | +1.6% | -2.9% | +1.9% | 1.4× |
| Q4 FY22 | 17 May 2022 | -2.0% | -8.8% | -11.1% | 0.8× |
| Q3 FY22 | 8 Feb 2022 | -1.3% | -8.8% | -11.2% | 1.0× |
| Q2 FY22 | 24 Oct 2021 | -15.7% | -11.1% | -17.8% | 1.6× |
| Average | +1.5% | +2.0% | +3.6% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +39.8% | +34.6% | +29.7% | — | — | — |
| Profit | +117.1% | +110.2% | +55.7% | — | — | — |
Key data
Delivery percentage
Over the last 20 sessions ACUTAAS settled 44.5% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 48.4%, so recent sessions are running 4.0 points lower than usual. The latest session ranks higher than 64% of the 1,283 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -3.61% | -5.09% | +19.23% | +19.41% | +27.77% | +124.04% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 393.2 | 432.8 | 329.7 | 436.9 |
| YoY chg | +43.0% | +40.3% | +59.1% | +42.7% |
| Net profit (₹ Cr) | 106.2 | 134.3 | 75.0 | 123.1 |
| YoY chg | +133.7% | +114.1% | +70.4% | +71.4% |
| Net margin | 27.0% | 31.0% | 22.7% | 28.2% |
| EPS | 13.10 | 16.04 | 9.04 | 15.24 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 32.66% · public 67.34%- Promoter
- Public and others
- Promoter
- 32.66%
- Public
- 67.34%
- Promoter change
- 0.00 pp
- Filed
- 13 Oct 2026
- FII
- 22.62%
- DII
- 19.40%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 14.44%
- Insurance
- 3.64%
- FPI
- 22.61%
- Retail ≤ ₹2L
- 13.57%
- HNI > ₹2L
- 7.58%
- NRI
- 1.23%
- Bodies corporate
- 1.28%
- Shareholders
- 1,47,026
+0.27 pp QoQ
+0.03 pp QoQ
+1.00 pp QoQ
+0.13 pp QoQ
-0.70 pp QoQ
-0.08 pp QoQ
+0.03 pp QoQ
+17.1% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| Nareshkumar Ramjibhai Patel | Promoter · Individual | 17.69% | 1.45Cr |
| Vaghasia Chetankumar Chhaganlal | Promoter · Individual | 14.97% | 1.23Cr |
| DHWANI GIRISHKUMAR CHOVATIA | Individual | 3.35% | 27.39L |
| GOVERNMENT PENSION FUND GLOBAL | FPI | 3.11% | 25.44L |
| KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK NIFTY ALPHA 50 INDEX FUND | Mutual fund | 2.86% | 23.41L |
| AXIS MAX LIFE INSURANCE LIMITED A/C NIFTY MOMENTUM QUALITY 50 FUND | Insurance | 2.04% | 16.71L |
| SBI NIFTY SMALLCAP 250 INDEX FUND | Mutual fund | 1.83% | 14.95L |
| MOTILAL OSWAL NIFTY SMALLCAP 250 INDEX FUND | Mutual fund | 1.81% | 14.83L |
| VANAJA SUNDAR IYER | Individual | 1.33% | 10.85L |
| Gevriya Nileshkumar Bhikhubhai | Promoter · Individual | 0.00% | 10 |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹2.50 | ₹2.50 |
| FY2025-26 | 1 | ₹1.50 | ₹1.50 |
| FY2024-25 | 1 | ₹3.00 | ₹1.50 |
| FY2023-24 | 1 | ₹3.00 | ₹1.50 |
| FY2022-23 | 1 | ₹3.00 | ₹1.50 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 17 Sept 2026 | 17 Sept 2026 | ₹2.50 | ₹2.50 |
| 18 Sept 2025 | — | ₹1.50 | ₹1.50 |
| 13 Sept 2024 | — | ₹3.00 | ₹1.50 |
| 18 Sept 2023 | — | ₹3.00 | ₹1.50 |
| 29 Jul 2022 | — | ₹3.00 | ₹1.50 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
52-week highs & lows
Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.
Book closures & record dates
NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 2.9 years ago
- Disclosures on record
- 24
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 2 Jun 2026 | Virendra Nath MishraDirector | Buy | 119 | ₹3.7L | 3,145.59 | 6.20L → 6.20L | 0.76%+0.00 pp | 7(2)told 1 Jun 2026 |
| 2 Jun 2026 | Virendra Nath MishraDirector | Sell | 40.0K | ₹12.4Cr | 3,090.53 | 6.60L → 6.20L | 0.76%-0.05 pp | 7(2)told 1 Jun 2026 |
| 10 Mar 2026 | Vijay GosarEmployee | Sell | 500 | ₹10.7L | 2,144.26 | 502 → 2 | 0.00%0.00 pp | 7(2)told 10 Mar 2026 |
| 20 Feb 2026 | MEHUL MANSUKHBHAI KOLADIAEmployee | Sell | 20.0K | ₹4.2Cr | 2,110.21 | 3.50L → 3.30L | 0.40%-0.02 pp | 7(2)told 19 Feb 2026 |
| 30 Dec 2025 | Bhavesh Mansukhbhai KotadiyaEmployee | Buy | 2.1K | ₹35.1L | 1,672.34 | — → 2.1K | 0.00% | 7(2)told 30 Dec 2025 |
| 20 May 2025 | Chetankumar Chhaganlal VaghasiaPromoter | Sell | 13.49L | ₹150.4Cr | 1,115.00 | 1.36Cr → 1.23Cr | 14.97%-1.65 pp | 7(2)told 20 May 2025 |
| 20 May 2025 | NARESHKUMAR RAMJIBHAI PATELPromoter | Sell | 13.49L | ₹150.4Cr | 1,115.00 | 1.58Cr → 1.45Cr | 17.69%-1.65 pp | 7(2)told 20 May 2025 |
| 6 Jan 2025 | RAM MOHAN LOKHANDEDirector | Sell | 400 | ₹8.5L | 2,130.00 | 2.0K → 1.6K | 0.00%0.00 pp | 7(2)told 2 Jan 2025 |
| 17 Sept 2024 | MEHUL MANSUKHBHAI KOLADIAEmployee | Sell | 25.0K | ₹3.9Cr | 1,540.41 | 2.00L → 1.75L | 0.43%-0.06 pp | 7(2)told 16 Sept 2024 |
| 28 Dec 2023 | CHETANKUMAR CHHAGANLAL VAGHASIAPromoter | Buy | 86.0K | ₹10.0Cr | 1,163.25 | 30.98L → 31.84L | 8.63%+0.23 pp | 7(2)told 28 Dec 2023 |
| 14 Sept 2022 | Virendra Nath MishraDirector | Sell | 3.00L | ₹31.1Cr | 1,037.25 | 6.30L → 3.30L | 0.91%-0.83 pp | 7(2)told 14 Sept 2022 |
| 14 Sept 2022 | Parulben VaghasiaPromoter | Sell | 3.00L | ₹31.1Cr | 1,037.25 | 32.38L → 29.38L | 8.06%-0.82 pp | 7(2)told 14 Sept 2022 |
| 14 Sept 2022 | Sheetalben N. PatelPromoter | Sell | 3.00L | ₹31.1Cr | 1,037.25 | 39.38L → 36.38L | 9.98%-0.82 pp | 7(2)told 14 Sept 2022 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Filings
CSVBulk & block deals · 24 Nov 2025
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 24 Nov 2025 | Buy · bulk | ISHARES CORE MSCI EMERGING MARKETS ETF | 5.30L | 1,852.12 | ₹98.2Cr |
| 19 May 2025 | Sell · block, also bulk | CHETANKUMAR CHHAGANLAL VAGHASIA · as AMIORG | 13.49L | 1,115.00 | ₹150.4Cr |
| 19 May 2025 | Buy · block, also bulk | KOTAK MAHINDRA MUTUAL FUND · as AMIORG | 13.49L | 1,115.00 | ₹150.4Cr |
| 19 May 2025 | Buy · block, also bulk | KOTAK MAHINDRA MUTUAL FUND. · as AMIORG | 13.49L | 1,115.00 | ₹150.4Cr |
| 19 May 2025 | Sell · block, also bulk | NARESHKUMAR RAMJIBHAI PATEL · as AMIORG | 13.49L | 1,115.00 | ₹150.4Cr |
| 2 May 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP · as AMIORG | 4.74L | 1,188.77 | ₹56.3Cr |
| 2 May 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP · as AMIORG | 4.74L | 1,188.04 | ₹56.3Cr |
| 21 Mar 2025 | Buy · bulk | THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND · as AMIORG | 2.43L | 2,425.43 | ₹59.0Cr |
| 30 Jan 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP · as AMIORG | 2.10L | 2,340.63 | ₹49.2Cr |
| 30 Jan 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP · as AMIORG | 2.10L | 2,342.16 | ₹49.1Cr |
| 29 Jan 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP · as AMIORG | 2.85L | 2,104.95 | ₹59.9Cr |
| 29 Jan 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP · as AMIORG | 2.84L | 2,102.18 | ₹59.8Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
- Price move > 100% in 1 year · since 9 Nov 2026 — One of the criteria NSE’s surveillance watches: price move > 100% in 1 year.
- High-low range > 150% in 12 months · since 9 Nov 2026 — One of the criteria NSE’s surveillance watches: high-low range > 150% in 12 months.
- P/E > 50 (4 quarters) · since 6 Dec 2024 — P/E above 50 on the last four quarters’ earnings.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 166.4 | 225.0 | 176.7 | 246.7 | 275.0 | 308.5 | 207.2 | 306.2 | 393.2 | 432.8 | 329.7 | 436.9 | |
| Other income | 3.5 | 1.3 | 1.0 | 8.4 | 1.7 | 5.8 | 15.9 | 9.8 | 4.7 | 11.1 | 1.8 | 5.1 | |
| Total income | 169.9 | 226.3 | 177.7 | 255.2 | 276.7 | 314.3 | 223.2 | 316.0 | 397.9 | 443.9 | 331.5 | 442.0 | |
| Total expenses | 146.2 | 188.8 | 157.8 | 205.1 | 213.3 | 231.4 | 165.1 | 219.9 | 253.2 | 260.1 | 227.6 | 274.7 | |
| └ Finance costs | 2.5 | 2.1 | 4.4 | 0.5 | 0.7 | 0.6 | 0.6 | 0.6 | 0.9 | 1.2 | 1.1 | 1.0 | |
| └ Depreciation | 3.8 | 4.9 | 6.2 | 6.8 | 6.3 | 7.3 | 8.1 | 8.4 | 9.8 | 9.6 | 9.8 | 12.7 | |
| Profit before tax | 23.7 | 37.2 | 20.0 | 50.0 | 63.3 | 82.8 | 58.1 | 96.2 | 144.7 | 183.8 | 103.9 | 167.4 | |
| Tax expense | 5.9 | 11.5 | 5.3 | 12.5 | 17.9 | 20.1 | 14.1 | 24.3 | 38.4 | 49.5 | 28.9 | 44.2 | |
| Net profit | 17.8 | 25.7 | 14.7 | 37.6 | 45.4 | 62.7 | 44.0 | 71.9 | 106.2 | 134.3 | 75.0 | 123.1 | |
| EPS | 2.42 | 3.43 | 1.83 | 4.69 | 5.67 | 3.90 | 5.41 | 8.82 | 13.19 | 16.09 | 9.07 | 15.29 | |
| Net margin | 10.70% | 11.41% | 8.31% | 15.23% | 16.53% | 20.33% | 21.24% | 23.47% | 27.02% | 31.03% | 22.75% | 28.18% | |
| PBT margin | 14.24% | 16.54% | 11.29% | 20.28% | 23.03% | 26.85% | 28.02% | 31.41% | 36.79% | 42.47% | 31.52% | 38.31% | |
| Tax rate | 24.85% | 30.98% | 26.38% | 24.93% | 28.25% | 24.29% | 24.22% | 25.29% | 26.58% | 26.94% | 27.83% | 26.42% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 27 Oct 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 766.9 | 968.0 | 1,095.9 | 1,426.9 | 1,549.3 | 1,695.6 | 1,984.0 | 2,220.9 | |
| Current assets | 470.1 | 571.4 | 495.8 | 760.6 | 791.6 | 789.9 | 881.3 | 1,012.0 | |
| └ Cash & equivalents | 30.5 | 34.1 | 29.7 | 58.2 | 185.2 | 172.5 | 215.6 | 288.8 | |
| └ Other bank balances | 28.1 | 70.3 | 23.6 | 221.3 | 63.7 | 68.2 | 9.3 | 18.1 | |
| └ Current investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Trade receivables | 230.3 | 206.0 | 206.4 | 241.8 | 290.5 | 291.5 | 362.6 | 358.3 | |
| └ Inventories | 119.2 | 164.2 | 156.7 | 157.5 | 179.9 | 191.0 | 231.3 | 280.3 | |
| Total equity | 594.0 | 645.1 | 682.8 | 1,211.8 | 1,320.1 | 1,439.1 | 1,710.8 | 1,920.4 | |
| └ Attributable to owners | 594.0 | 630.5 | 674.0 | 1,202.1 | 1,309.6 | 1,413.6 | 1,653.6 | 1,857.4 | |
| └ Non-controlling interest | — | 14.6 | 8.8 | 9.7 | 10.5 | 25.4 | 57.2 | 62.9 | |
| └ Share capital | 36.4 | 36.9 | 36.9 | 40.9 | 40.9 | 40.9 | 40.9 | 40.9 | |
| Borrowings | 3.6 | 101.2 | 216.6 | 6.2 | 8.2 | 0.2 | 26.5 | 5.9 | |
| └ Current | 3.0 | 58.3 | 103.0 | 3.6 | 8.2 | 0.2 | 26.5 | 5.9 | |
| └ Non-current | 0.6 | 42.9 | 113.6 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Trade payables | 142.0 | 172.6 | 134.6 | 147.7 | 156.0 | 149.2 | 153.9 | 155.8 | |
| Current liabilities | 162.8 | 269.1 | 285.2 | 196.2 | 202.2 | 219.2 | 230.8 | 253.4 | |
| Total liabilities | 173.0 | 322.9 | 413.1 | 215.1 | 229.2 | 256.6 | 273.2 | 300.5 | |
| Net debt | (55.1) | (3.2) | 163.3 | (273.3) | (240.7) | (240.4) | (198.3) | (300.9) | |
| Debt / equity | 0.01 | 0.16 | 0.32 | 0.01 | 0.01 | 0.00 | 0.02 | 0.00 | |
| Current ratio | 2.89 | 2.12 | 1.74 | 3.88 | 3.91 | 3.60 | 3.82 | 3.99 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 65.5 | 55.9 | 125.2 | 46.3 | 118.3 | 136.5 | 292.2 | 215.9 | |
| └ Capex | (96.4) | (112.5) | (280.4) | (79.5) | (194.6) | (141.2) | (328.0) | (123.9) | |
| Free cash flow | (30.9) | (56.7) | (155.2) | (33.2) | (76.3) | (4.6) | (35.8) | 92.0 | |
| Investing cash flow | (33.0) | (201.0) | (365.4) | (279.2) | (223.9) | (140.1) | (265.9) | (127.8) | |
| Financing cash flow | (12.3) | 148.7 | 239.4 | 261.4 | 261.1 | (9.1) | 4.1 | (40.6) | |
| └ Dividends paid | (10.9) | (10.9) | (10.9) | (12.3) | (12.3) | 0.0 | (12.3) | (20.5) | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | 20.2 | 3.5 | (0.8) | 28.5 | 155.5 | (12.8) | 30.3 | 47.6 |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →ACUTAAS at a glance
- ACUTAAS closed at ₹3,833.5 on 20 Nov 2026, -3.61% on the day, +124.0% over one year, 7.2% below its 52-week high of ₹4,130.
- Delivery was 50.4% of traded quantity on 20 Nov 2026, the 64th percentile of its own 1,283 sessions with a reading (20-session average 44.5%, 1-year average 48.4%).
- Market capitalisation is ₹31,385 crore at a trailing P/E of 71.5 (trailing EPS ₹53.64).
- Q2 FY27 results (consolidated, filed 27 Oct 2026): revenue ₹437 crore (+42.7% year on year), net profit ₹123 crore (+71.4%); the price moved -2.2% on the first session after.
- Promoters held 32.66% at 30 Sept 2026, unchanged on the previous filing.
- Q3 FY27 results are expected between 28 Jan 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
- TOTORNTPHARMTorrent Pharmaceuticals Limited4,689.50+1.70%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE